Stay updated on Zolbetuximab in CLDN18.2+ Gastric Cancer Clinical Trial
Sign up to get notified when there's something new on the Zolbetuximab in CLDN18.2+ Gastric Cancer Clinical Trial page.
![Latest website image capture](/pages/_next/image?url=https%3A%2F%2Fs3.us-west-2.amazonaws.com%2Fvp-files-ore%2Fresources%2F12months%2FVUlGlfMBv7XabLNFO1uRXkATUTA.uncropped.jpg&w=3840&q=75)
Latest updates to the Zolbetuximab in CLDN18.2+ Gastric Cancer Clinical Trial page
- ChecktodayNo Change Detected
- CheckyesterdayNo Change Detected
- Check3 days agoNo Change Detected
- Check4 days agoChange DetectedThe website has been updated to version v2.10.0, adding 5 more interventions/treatments and noting that the study now has 26 locations, while the previous version v2.9.7 has been removed.SummaryDifference0.2%
- Check5 days agoNo Change Detected
- Check11 days agoChange DetectedThe website has been updated to Revision v2.9.7 from v2.9.6.SummaryDifference0.1%
- Check16 days agoChange DetectedDifference0.1%
- Check18 days agoChange DetectedDifference0.1%
- Check21 days agoChange DetectedDifference0.1%
- Check24 days agoChange DetectedThe value Nivolumab Oxaliplatin has been changed to Oxaliplatin Nivolumab in the study details section of the webpage. This change represents an adjustment in the order of the drug names used in the study protocol.SummaryDifference0.1%
Stay in the know with updates to Zolbetuximab in CLDN18.2+ Gastric Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Zolbetuximab in CLDN18.2+ Gastric Cancer Clinical Trial page.